The Raji lymphoblast-like cell line was used as a CD19-expressing cell line for target in cytotoxicity assays and in vivo tumor challenges (ATCC CCL86). Peripheral blood from anonymous donors was used to isolate peripheral blood mononuclear cells (PBMC) through Ficoll-Paque Plus (GE Healthcare Life Sciences 17–1440-02) density gradient separation. Dynabeads® Human T-Activator CD3/CD28 beads (ThermoFisher Scientific 11132D) were used to activate T lymphocytes through incubation for 72 hours. After 72 hours, the T cells were harvested and beads removed through a magnetic column system. Once the beads were removed, 5 × 105 cells were transduced in R10 at 4 × 107 TU/mL. These cells were kept in culture in RPMI plus 10% FBS (R10) with rhuIL-2 (R&D Systems 202-IL-500) and reactivated with the anti-CD3/CD28 beads every 7–10 d.
Umbilical cord blood units were obtained through anonymous collection from the delivery rooms at UCLA. Isolation of human CD34+ cells were obtained through immunomagnetic beads (MACS CD34 MicroBead Separation Kit, Miltenyi 130–046-702) and stored at −170°C. After thawing, these cells were prestimulated for 14 hours in X-Vivo15 medium (Lonza 04–744Q) with human stem cell factor (SCF), Flt-3 ligand, and thrombopoietin (R&D Systems 255-SC-200, 308-FK and 288-TP). 1 × 106 cells in 1 mL with wells coated with recombinant human fibronectin fragment RetroNectin (Clontech T100B) were transduced at a vector concentration of 5 × 107 TU/mL for 24 hours.18 Myeloid differentiation conditions were created by culture for 12–15 d in Iscove's Modified Dulbecco's medium (IMDM) (Corning 10–016-CM) with 10% FBS, plus SCF and IL-3.18
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.